Nanovaccines against Cervical Cancer: Reliable Strategies to Circumvent Limitations of Traditional Therapeutic Vaccines
Cervical cancer ranks fourth in terms of diagnosis and cancer-related deaths in women worldwide. Despite the approval of prophylactic vaccines against cervical cancers, these vaccines are not able to eradicate the existing ones. Therefore, various platforms have been developed to design therapeutic...
Saved in:
Main Authors: | Enwa Felix Oghenemaro, Safia Obaidur Rab, Ebraheem Abdu Musad Saleh, Asmaa F. Kassem, Jasur Rizaev, Deepak Nathiya, Parjinder Kaur, M. Ravi Kumar, Karam Kadhim, Ahmed M. Hashim |
---|---|
Format: | Article |
Language: | English |
Published: |
Tabriz University of Medical Sciences
2025-04-01
|
Series: | Advanced Pharmaceutical Bulletin |
Subjects: | |
Online Access: | https://apb.tbzmed.ac.ir/PDF/apb-15-46.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biomimetic nanovaccines in cancer therapy: mechanisms, efficacy, and clinical translation
by: Dilinaer Wusiman, et al.
Published: (2025-10-01) -
Revolutionizing Cancer Vaccine: The Power of Advanced Nanotechnology
by: Saranya Udayakumar, et al.
Published: (2025-06-01) -
NIR light-driven transformable liquid metal-based nanovaccines restrain postoperative colorectal cancer recurrence
by: Zheng Dai, et al.
Published: (2025-09-01) -
One-step preparation of a self-assembled bioconjugate nanovaccine against Brucella
by: Jing Huang, et al.
Published: (2023-12-01) -
CEA-Functionalized Gold Nanoparticles as a Nanovaccine Platform: In Vitro Evaluation of Cytocompatibility, Cellular Uptake, and Antigen Processing
by: Razvan-Septimiu Zdrehus, et al.
Published: (2025-06-01)